Company intelligence / Profile preview

BioPartners

Ownership: Private
Development stage: Other

Overview

BioPartners develops and commercializes innovative formulations and novel delivery systems for first-generation biopharmaceuticals in endocrinology, multiple sclerosis, and virology. They are advancing a prolonged-release recombinant human growth hormone that reduces injection frequency from daily to weekly—a significant advance in hGH therapy. The company has an international presence with headquarters in Switzerland and an affiliate in Germany, collaborating widely for product development and distribution.[2] Clinical results are not detailed but the lead program was described as nearing regulatory submission.

Therapeutic areas: EndocrinologyNeurologyInfectious Diseases
Modalities: Recombinant proteins (e.g., recombinant human growth hormone)First-generation biopharmaceuticals with novel delivery systems[2]
Industry: Biotech

Partnerships

Collaborations with leading development/service partners; negotiating major distribution agreements globally [2]

Beyond the preview

Go deeper on BioPartners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioPartners.